Sigal A, Neher R, Lessells R
Nat Rev Microbiol. 2024; .
PMID: 39587352
DOI: 10.1038/s41579-024-01125-y.
Hussen B, Najmadden Z, Abdullah S, Rasul M, Mustafa S, Ghafouri-Fard S
Cell Commun Signal. 2024; 22(1):329.
PMID: 38877530
PMC: 11179281.
DOI: 10.1186/s12964-024-01713-8.
Kim S, Waghmare A, Hijano D
Front Pediatr. 2024; 11:1339239.
PMID: 38304442
PMC: 10830789.
DOI: 10.3389/fped.2023.1339239.
Dharan N, Sasson S, Ahlenstiel G, Andersen C, Bloch M, Buckland G
PLoS One. 2023; 18(11):e0289907.
PMID: 37910527
PMC: 10619805.
DOI: 10.1371/journal.pone.0289907.
Lee C, Liu Y
J Acute Med. 2023; 13(2):47-57.
PMID: 37465825
PMC: 10351401.
DOI: 10.6705/j.jacme.202306_13(2).0001.
Phylogenetic analysis of HA and NA genes of influenza A viruses in immunosuppressed inpatients in Beijing during the 2018-2020 influenza seasons.
Liu Y, Wang Y, Wang Y, Mai H, Chen Y, Zhang Y
Virol J. 2023; 20(1):101.
PMID: 37237356
PMC: 10215044.
DOI: 10.1186/s12985-023-02067-2.
A Characterization and an Evolutionary and a Pathogenicity Analysis of Reassortment H3N2 Avian Influenza Virus in South China in 2019-2020.
Liu T, Huang Y, Xie S, Xu L, Chen J, Qi W
Viruses. 2022; 14(11).
PMID: 36423183
PMC: 9692712.
DOI: 10.3390/v14112574.
Preclinical and clinical developments for combination treatment of influenza.
Koszalka P, Subbarao K, Baz M
PLoS Pathog. 2022; 18(5):e1010481.
PMID: 35551301
PMC: 9098076.
DOI: 10.1371/journal.ppat.1010481.
Prolonged Shedding of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at High Viral Loads Among Hospitalized Immunocompromised Persons Living With Human Immunodeficiency Virus (HIV), South Africa.
Meiring S, Tempia S, Bhiman J, Buys A, Kleynhans J, Makhasi M
Clin Infect Dis. 2022; 75(1):e144-e156.
PMID: 35134129
PMC: 8903337.
DOI: 10.1093/cid/ciac077.
Clinical characteristics, risk factors and antiviral treatments of influenza in immunosuppressed inpatients in Beijing during the 2015-2020 influenza seasons.
Liu Y, Wang Y, Mai H, Chen Y, Liu B, Liu Y
Virol J. 2022; 19(1):11.
PMID: 35033116
PMC: 8760682.
DOI: 10.1186/s12985-021-01739-1.
Prolonged SARS-CoV-2 Infection in Patients with Lymphoid Malignancies.
Lee C, Shah M, Hoyos D, Solovyov A, Douglas M, Taur Y
Cancer Discov. 2021; 12(1):62-73.
PMID: 34753749
PMC: 8758535.
DOI: 10.1158/2159-8290.CD-21-1033.
Recurrent SARS-CoV-2 RNA positivity and prolonged viral shedding in a patient with COVID-19: a case report.
Xiao C, Chen L, Li Y
BMC Infect Dis. 2021; 21(1):1076.
PMID: 34663257
PMC: 8523010.
DOI: 10.1186/s12879-021-06776-3.
Temporal differences in culturable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) from the respiratory and gastrointestinal tracts in a patient with moderate coronavirus disease 2019 (COVID-19).
Audsley J, Holmes N, Mordant F, Douros C, Zufan S, Nguyen T
Infect Control Hosp Epidemiol. 2021; 43(9):1286-1288.
PMID: 33966675
PMC: 8144808.
DOI: 10.1017/ice.2021.223.
Time to SARS-CoV-2 clearance among patients with cancer and COVID-19.
Xu W, Piper-Vallillo A, Bindal P, Wischhusen J, Patel J, Costa D
Cancer Med. 2021; 10(5):1545-1549.
PMID: 33560590
PMC: 7940218.
DOI: 10.1002/cam4.3708.
Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19.
Li T, Cao Z, Chen Y, Cai M, Zhang L, Xu H
J Med Virol. 2020; 93(1):506-512.
PMID: 32644223
PMC: 7362127.
DOI: 10.1002/jmv.26280.
Characterization of neuraminidase inhibitor-resistant influenza virus isolates from immunocompromised patients in the Republic of Korea.
Kim H, Lee N, Kim M, Kang C, Chung Y
Virol J. 2020; 17(1):94.
PMID: 32631440
PMC: 7338124.
DOI: 10.1186/s12985-020-01375-1.
Decreased B Cells on Admission Associated With Prolonged Viral RNA Shedding From the Respiratory Tract in Coronavirus Disease 2019: A Case-Control Study.
Hao S, Lian J, Lu Y, Jia H, Hu J, Yu G
J Infect Dis. 2020; 222(3):367-371.
PMID: 32474608
PMC: 7542891.
DOI: 10.1093/infdis/jiaa311.
Quantifying between-Host Transmission in Influenza Virus Infections.
Johnson K, Ghedin E
Cold Spring Harb Perspect Med. 2019; 10(8).
PMID: 31871239
PMC: 7397841.
DOI: 10.1101/cshperspect.a038422.
Immunogenicity of high-dose influenza vaccination in patients with primary central nervous system malignancy.
Strowd R, Russell G, Hsu F, Carter A, Chan M, Tatter S
Neurooncol Pract. 2019; 5(3):176-183.
PMID: 31385974
PMC: 6655350.
DOI: 10.1093/nop/npx035.
Nasal Nitric Oxide in Primary Immunodeficiency and Primary Ciliary Dyskinesia: Helping to Distinguish Between Clinically Similar Diseases.
Zysman-Colman Z, Kaspy K, Alizadehfar R, NyKamp K, Zariwala M, Knowles M
J Clin Immunol. 2019; 39(2):216-224.
PMID: 30911954
PMC: 6870987.
DOI: 10.1007/s10875-019-00613-8.
